Long-term effects of alcohol policies: An economic perspective

Addiction

Volumn 105, Issue 3, 2010, Pages 395-397

  Baal, Pieter Van ^a,b   Feenstra, Talitha L ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alcohol; Cost effectiveness analysis; Modeling

Indexed keywords

EID: 76249114841     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02847.x     Document Type: Note

References (10)

1. Meier P. S., Purshouse R., Brennan A. Policy options for alcohol price regulation: the importance of modelling population heterogeneity. Addiction 2010 105 : 383 393.
2. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009 373 : 2223 2233.
3. Barendregt J. J., Bonneux L., van der Maas P. J. The health care costs of smoking. N Engl J Med 1997 337 : 1052 1057.
4. van Baal P. H., Polder J. J., de Wit G. A., Hoogenveen, R. T., Feenstra T. L., Boshuizen H. C. et al. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med 2008 5 : e29.
5. van den Berg M., van Baal P. H., Tariq L., Schuit A. J., de Wit G. A., Hoogenveen R. T. The cost-effectiveness of increasing alcohol taxes: a modelling study. BMC Med 2008 6 : 36.
6. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997 16 : 33 64.
7. Feenstra T. L., van Baal P. H., Gandjour A., Brouwer W. B. Future costs in economic evaluation. A comment on Lee. J Health Econ 2008 27 : 1645 1649 discussion 1650-1.
8. Brouwer W. B., Niessen L. W., Postma M. J., Rutten F. F. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ 2005 331 : 446 448.
9. Bleichrodt H., Quiggin J. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? J Health Econ 1999 18 : 681 708.
10. Buxton M. J., Drummond M. F., Van Hout B. A., Prince R. L., Sheldon T. A., Szucs T. et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997 6 : 217 227.